237 related articles for article (PubMed ID: 30499113)
1. A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.
Rizvi I; Nath S; Obaid G; Ruhi MK; Moore K; Bano S; Kessel D; Hasan T
Photochem Photobiol; 2019 Jan; 95(1):419-429. PubMed ID: 30499113
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent.
Rizvi I; Obaid G; Bano S; Hasan T; Kessel D
Lasers Surg Med; 2018 Jul; 50(5):499-505. PubMed ID: 29527710
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
4. Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells.
Obaid G; Jin W; Bano S; Kessel D; Hasan T
Photochem Photobiol; 2019 Jan; 95(1):364-377. PubMed ID: 30125366
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.
Wang Y; Gonzalez M; Cheng C; Haouala A; Krueger T; Peters S; Decosterd LA; van den Bergh H; Perentes JY; Ris HB; Letovanec I; Debefve E
Lasers Surg Med; 2012 Apr; 44(4):318-24. PubMed ID: 22362489
[TBL] [Abstract][Full Text] [Related]
6. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
7. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
8. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
9. PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy.
Ichikawa K; Hikita T; Maeda N; Takeuchi Y; Namba Y; Oku N
Biol Pharm Bull; 2004 Mar; 27(3):443-4. PubMed ID: 14993821
[TBL] [Abstract][Full Text] [Related]
10. Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
Quinlan JA; Inglut CT; Srivastava P; Rahman I; Stabile J; Gaitan B; Arnau Del Valle C; Baumiller K; Gaur A; Chiou WA; Karim B; Connolly N; Robey RW; Woodworth GF; Gottesman MM; Huang HC
Adv Sci (Weinh); 2024 May; 11(17):e2302872. PubMed ID: 38445882
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of cancer with liposomal photosensitizers.
Düzgüneş N; Piskorz J; Skupin-Mrugalska P; Goslinski T; Mielcarek J; Konopka K
Ther Deliv; 2018 Nov; 9(11):823-832. PubMed ID: 30444459
[TBL] [Abstract][Full Text] [Related]
12. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
Mir Y; Elrington SA; Hasan T
Nanomedicine; 2013 Oct; 9(7):1114-22. PubMed ID: 23485748
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N
Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098
[TBL] [Abstract][Full Text] [Related]
14. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
15. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
16. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
17. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Young LH; Howard MA; Hu LK; Kim RY; Gragoudas ES
Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023
[TBL] [Abstract][Full Text] [Related]
19. A Physiochemical,
Shah N; Soma SR; Quaye MB; Mahmoud D; Ahmed S; Malkoochi A; Obaid G
ACS Appl Bio Mater; 2024 Jun; ():. PubMed ID: 38934648
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of photodynamic therapy via a sequential targeting protocol.
Kessel D; Reiners JJ
Photochem Photobiol; 2014; 90(4):889-95. PubMed ID: 24617972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
